Thursday, June 28, 2012

Top Stocks For 2012-1-15-17

Monotype Imaging Holdings Inc. (Nasdaq:TYPE) is now accepting entries through Oct. 28, 2011, for its 2nd annual Web Font Awards, the international competition that recognizes websites that incorporate exceptional use of Web fonts. Winners will be announced following a live judging event during the Future of Web Design conference, Nov. 7-9, in New York City.

Monotype Imaging Holdings Inc., through its subsidiaries, provides text imaging solutions worldwide. The company involves in developing, marketing, and licensing technologies and fonts for displaying and printing digital text.

Crown Equity Holdings, Inc. (CRWE)

Crown Equity Holdings Inc. (CRWE) is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.

Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: “We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market.”

There are several reasons why corporations are considering VoIP (Voice over Internet Protocol) based systems. Among the most prevalent are call cost reductions, increased scalability and flexibility, and the ease of use and installation.
There are some benefits of VoIP (Voice over Internet Protocol) following:
Cost reduction
Flexibility
Scalability

Crown Equity Holdings Inc’s selection of Core Link reflects recent diversification beyond CRWE’s original charter as a provider of services and knowledge to small business owners taking their own companies public. In addition to these services, Crown Equity Holdings Inc has transitioned into a multifaceted media organization that publishes clients’ news online; sells advertising adjacent with its digital network targeted at a high-income audience; designs, hosts and maintains websites; produces marketing videos from concept to final product; crafts press releases and articles for maximum SEO; develops email campaigns; and forges branding campaigns to bolster client company images.

Crown Equity Holdings, Inc. together with its digital network currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

For more information, visit http://www.crownequityholdings.com

S1 Corporation (Nasdaq:SONE) announced that it has terminated its merger agreement with Fundtech Ltd. and received an $11.9 million termination fee. The Special Meeting of Stockholders scheduled for October 13, 2011 has been canceled.

S1 Corporation provides payments and financial services software solutions in the United States and internationally. The company operates in three segments: Banking: Payments, Banking: Large Financial Institution (FI), and Community Financial Institution (FI).

OncoGenex Pharmaceuticals, Inc. (Nasdaq:OGXI) announced that the company has successfully completed an amendment to the approved SPA with the U.S. Food and Drug Administration (FDA) to expand the inclusion criteria for the Prostate Cancer SATURN Clinical Trial - a Phase III study testing whether their experimental drug custirsen, also known as OGX-011/TV-1011, can improve quality of life by reducing cancer pain for more than 12 weeks in men with metastatic castrate-resistant prostate cancer (mCRPC).

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.

No comments:

Post a Comment